课题基金 / 基金详情

PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION

PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
垂体瘤监测：致病相关性
批准号：
7606126
负责人：
SHLOMO MELMED
金额：
$0.08万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-02-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7606126
关键词：
AdultComputer Retrieval of Information on Scientific Projects DatabaseDoseDrug KineticsFundingGrantInstitutionLabelMedical SurveillancePharmacodynamicsPhasePituitary NeoplasmsResearchResearch PersonnelResourcesSafetySourceTitrationsUnited States National Institutes of Healthdesigngrowth hormone deficiencyimmunogenicityr-hGH-M

项目摘要

项目成果

SHLOMO MELMED的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is a Phase 1, multicenter, open-label, dose-titration of Albutropin in subjects with adult onset growth hormone deficiency. The study is designed to evaluate the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of difference doses of subcutaneously administered rHA-rHGH in subjects with adult onset growth hormone deficiency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ph 2 Multicenter study of seliciclib for Cushing Disease IND 120,848 (10/10/2017)
  • 批准号：
    10003845
  • 项目类别：
  • 资助金额：
    $46.78万
  • 财政年份：
    2018
  • 负责人：
    SHLOMO MELMED
  • 依托单位：
    CEDARS-SINAI MEDICAL CENTER
Mechanisms for GH action on epithelial cells
  • 批准号：
    10578571
  • 项目类别：
  • 资助金额：
    $36.74万
  • 财政年份：
    2018
  • 负责人：
    SHLOMO MELMED
  • 依托单位：
    CEDARS-SINAI MEDICAL CENTER
Mechanisms for GH action on epithelial cells
  • 批准号：
    9893867
  • 项目类别：
  • 资助金额：
    $38.25万
  • 财政年份：
    2018
  • 负责人：
    SHLOMO MELMED
  • 依托单位：
    CEDARS-SINAI MEDICAL CENTER
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovit
  • 批准号：
    8773516
  • 项目类别：
  • 资助金额：
    $23.44万
  • 财政年份：
    2014
  • 负责人：
    SHLOMO MELMED
  • 依托单位：
    CEDARS-SINAI MEDICAL CENTER